Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Surgical Bioprosthesis Aortic Valve Replacement Vs. Myval Balloon-Expandable THV Series in Patients Aged 65 to 75 With Symptomatic Severe Aortic Stenosis Judged Eligible by Heart Team

NCT06861361 is registered in ClinicalTrials.gov with Ceric Sàrl as lead sponsor.

NCT NCT06861361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06861361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Surgical Bioprosthesis Aortic Valve Replacement Vs. Myval Balloon-Expandable THV Series in Patients Aged 65 to 75 With Symptomatic Severe Aortic Stenosis Judged Eligible by Heart Team
Lead sponsor
Ceric Sàrl
Phase
Not applicable
Overall status
Recruiting
Start date
May 15, 2025
Completion date
September 30, 2037
Enrollment
1,180 (estimated)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic severe aortic stenosis